In 2025, both the procurement amount and volume of drugs negotiated under the national medical insurance catalog achieved double growth.

The "National Medical Insurance Information Platform Annual Report on Pharmaceutical Procurement" was released in Suzhou, Jiangsu on November 14. The report shows that since the medical insurance catalog began dynamic adjustments in 2018, a cumulative total of 530 drugs had been included through national negotiations by 2024. Compared with 2024 data, 84.2% of nationally negotiated drugs achieved growth in both procurement value and procurement volume in 2025.